Selumetinib
CAS 606143-52-6 3 FDA-DMF suppliersSmall Molecule
Overview
Selumetinib is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1614701).
Patent & exclusivity (US)
Per the FDA Orange Book (4 approved US products), the latest listed US patent on Selumetinib expires 25 Mar 2029 and exclusivity 19 Nov 2032. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- 6-(4-bromo-2-chloroanilino)-7-fluoro-N-(2-hydroxyethoxy)-3-methylbenzimidazole-5-carboxamide
- Canonical SMILES
- CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)Cl)C(=O)NOCCO
- InChIKey
- CYOHGALHFOKKQC-UHFFFAOYSA-N
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.